Dhan Chand/LinkedIn
Jan 27, 2025, 07:20
Dhan Chand: BOT + BAL is redefining the treatment paradigm in colorectal cancer
Dhan Chand, Vice President of Research at Agenus, shared a post on LinkedIn:
“BOT + BAL is redefining the treatment paradigm in colorectal cancer, with unprecedented responses and no recurrences in the neoadjuvant setting.
This approach is turning ‘cold’ tumors ‘hot’.
For patients, this means a real chance at complete tumor clearance and new hope for a cancer-free future.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 24, 2025, 23:27
Feb 24, 2025, 15:25
Feb 24, 2025, 14:55
Feb 24, 2025, 14:51
Feb 24, 2025, 14:45
Feb 24, 2025, 14:22
Feb 24, 2025, 14:08
Feb 24, 2025, 14:00
Feb 24, 2025, 13:59